Thurmond Eye Associates, PLLC
Thurmond Eye Associates, PLLC was paid $2.27M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 92014, Ophthalmological services: medical examination and evaluation, comprehensive, established patient — 31% of everything it billed.
33Billing provider infoTHURMOND EYE ASSOCIATES, PLLC
WESLACO, TX 78596
WESLACO, TX 78596
33aNPI1629023460assigned 05/23/2006
33bProvider typeSpecialist
28Total paid$2.27M
24GClaims82,809
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Texas
Rank by total paid#21 of 382
Median peer was paid$29K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,391 | $133K | |
| 2019 | 10,660 | $112K | |
| 2020 | 8,886 | $170K | |
| 2021 | 15,943 | $535K | |
| 2022 | 15,411 | $570K | |
| 2023 | 12,437 | $486K | |
| 2024incomplete | 7,081 | $264K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 31% | 20,057 | 19,787 | $702K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 14% | 11,671 | 11,278 | $313K |
| J9035 | Injection, bevacizumab, 10 mg | 11% | 7,124 | 6,711 | $246K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 9.4% | 2,265 | 2,216 | $212K |
| S0621 | Routine ophthalmological examination including refraction; established patient | 8.3% | 4,831 | 4,546 | $189K |
| 67028 | Intravitreal injection of a pharmacologic agent | 7.1% | 7,693 | 7,134 | $161K |
| 92134 | 4.0% | 8,188 | 8,008 | $92K | |
| S0620 | Routine ophthalmological examination including refraction; new patient | 2.8% | 1,678 | 1,543 | $64K |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 2.7% | 2,659 | 2,562 | $61K |
| V2020 | Frames, purchases | 2.6% | 4,416 | 4,278 | $59K |
| 92250 | 2.6% | 3,261 | 3,230 | $58K | |
| 92133 | 1.2% | 2,243 | 2,226 | $27K |
29 more codes
| 92083 | <1% | 1,751 | $22K | |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 1,038 | $22K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 487 | $10K |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 297 | $6K |
| 92015 | Determination of refractive state | <1% | 452 | $6K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 185 | $3K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 249 | $3K |
| V2025 | Deluxe frame | <1% | 343 | $3K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 468 | $3K |
| 76519 | <1% | 51 | $1K | |
| CP005 | <1% | 20 | $980.00 | |
| V2744 | Tint, photochromatic, per lens | <1% | 146 | $942.12 |
| 92002 | <1% | 13 | $700.90 | |
| 92020 | <1% | 96 | $569.31 | |
| 92136 | <1% | 32 | $493.17 | |
| V2107 | Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens | <1% | 27 | $386.98 |
| CP003 | <1% | 40 | $221.47 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 55 | $90.96 |
| 3072F | 0% | 81 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 82 | $0.00 |
| 3284F | 0% | 203 | $0.00 | |
| 2023F | 0% | 13 | $0.00 | |
| 4177F | 0% | 33 | $0.00 | |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | 0% | 30 | $0.00 |
| 2027F | 0% | 204 | $0.00 | |
| 5010F | 0% | 66 | $0.00 | |
| 2022F | 0% | 167 | $0.00 | |
| V2750 | Anti-reflective coating, per lens | 0% | 80 | $0.00 |
| 99490 | Ccm add 20min | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARTANOWICZ, WILLIAM (ADMINISTRATOR)